# Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation

> **NCT03492749** · — · COMPLETED · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 80 (estimated)

## Conditions studied

- Bone Marrow Disease

## Interventions

- **DIAGNOSTIC_TEST:** Saliva monitoring

## Key facts

- **NCT ID:** NCT03492749
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2020-02
- **Final completion:** 2020-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03492749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03492749, "Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03492749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*